These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 11019435)

  • 1. XIII International AIDS Conference highlights.
    Laurence J
    AIDS Read; 2000 Sep; 10(9):506-7. PubMed ID: 11019435
    [No Abstract]   [Full Text] [Related]  

  • 2. Trends in causes of death among persons with acquired immunodeficiency syndrome in the era of highly active antiretroviral therapy, San Francisco, 1994-1998.
    Louie JK; Hsu LC; Osmond DH; Katz MH; Schwarcz SK
    J Infect Dis; 2002 Oct; 186(7):1023-7. PubMed ID: 12232845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population-based patterns of human immunodeficiency virus-related Hodgkin lymphoma in the Greater San Francisco Bay Area, 1988-1998.
    Glaser SL; Clarke CA; Gulley ML; Craig FE; DiGiuseppe JA; Dorfman RF; Mann RB; Ambinder RF
    Cancer; 2003 Jul; 98(2):300-9. PubMed ID: 12872349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in opportunistic infections in the pre- and post-highly active antiretroviral therapy eras among HIV-infected children in the Perinatal AIDS Collaborative Transmission Study, 1986-2004.
    Nesheim SR; Kapogiannis BG; Soe MM; Sullivan KM; Abrams E; Farley J; Palumbo P; Koenig LJ; Bulterys M
    Pediatrics; 2007 Jul; 120(1):100-9. PubMed ID: 17606567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fewer AIDS deaths and illnesses: new information.
    James JS
    AIDS Treat News; 1997 Feb; (No 265):1-3. PubMed ID: 11364239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of acquired immunodeficiency syndrome-associated opportunistic diseases and the effect of treatment on a cohort of 1115 patients infected with human immunodeficiency virus, 1989-1997.
    San-Andrés FJ; Rubio R; Castilla J; Pulido F; Palao G; de Pedro I; Costa JR; del Palacio A
    Clin Infect Dis; 2003 May; 36(9):1177-85. PubMed ID: 12715314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The epidemiology of human immunodeficiency virus-associated neurological disease in the era of highly active antiretroviral therapy.
    Sacktor N
    J Neurovirol; 2002 Dec; 8 Suppl 2():115-21. PubMed ID: 12491162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reports from the 6th Conference on Retroviruses and Opportunistic Infections.
    Boyle BA
    AIDS Read; 1999; 9(3):157-9, 166. PubMed ID: 12728899
    [No Abstract]   [Full Text] [Related]  

  • 9. Prophylaxis and treatment of opportunistic infection in patients on HAART.
    Tantisiriwat W; Powderly WG
    AIDS Read; 1999; 9(2):122-30. PubMed ID: 12728894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The changing pattern of AIDS-defining illnesses with the introduction of highly active antiretroviral therapy (HAART)in a London clinic.
    Ives NJ; Gazzard BG; Easterbrook PJ
    J Infect; 2001 Feb; 42(2):134-9. PubMed ID: 11531320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decline in the rate of specific opportunistic infections at San Francisco General Hospital, 1994-1997.
    Holtzer CD; Jacobson MA; Hadley WK; Huang L; Stanley HD; Montanti R; Wong MK; Stansell JD
    AIDS; 1998 Oct; 12(14):1931-3. PubMed ID: 9792398
    [No Abstract]   [Full Text] [Related]  

  • 12. [Opportunistic diseases again on the increase? Study shows tendency for change in the trend].
    Marquardt T; Jablonowski H
    MMW Fortschr Med; 2002 Apr; 144 Suppl 1():33-9. PubMed ID: 12043071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selected topics from the XIII International AIDS Conference.
    Boyle BA
    AIDS Read; 2000 Aug; 10(8):456-9. PubMed ID: 10967798
    [No Abstract]   [Full Text] [Related]  

  • 14. Human immunodeficiency virus/acquired immunodeficiency syndrome and cancer: past, present, and future.
    Engels EA; Goedert JJ
    J Natl Cancer Inst; 2005 Mar; 97(6):407-9. PubMed ID: 15769998
    [No Abstract]   [Full Text] [Related]  

  • 15. Impact of highly active antiretroviral therapy on incidence and management of human immunodeficiency virus-related opportunistic infections.
    Hung CC; Chang SC
    J Antimicrob Chemother; 2004 Nov; 54(5):849-53. PubMed ID: 15456733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opportunistic infections and other AIDS-defining illnesses in Poland in 2000-2002.
    Podlasin RB; Wiercinska-Drapalo A; Olczak A; Beniowski M; Smiatacz T; Malolepsza E; Juszczyk J; Leszczyszyn-Pynka M; Mach T; Mian M; Knysz B; Horban A
    Infection; 2006 Aug; 34(4):196-200. PubMed ID: 16896577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. XIII international AIDS Conference: new thoughts on treatment in all worlds.
    Laurence J
    AIDS Read; 2000 Aug; 10(8):452-3. PubMed ID: 10967797
    [No Abstract]   [Full Text] [Related]  

  • 18. The decline of incident cases of HIV-associated neurological disorders in San Francisco, 1991-2003.
    Dilley JW; Schwarcz S; Loeb L; Hsu L; Nelson K; Scheer S
    AIDS; 2005 Mar; 19(6):634-5. PubMed ID: 15802986
    [No Abstract]   [Full Text] [Related]  

  • 19. [Opportunistic diseases. Risk can be estimated].
    Marquardt T; Jablonowski H
    MMW Fortschr Med; 2003 Apr; 145 Spec No 1():33-7. PubMed ID: 15011582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trends in bacteremia in the pre- and post-highly active antiretroviral therapy era among HIV-infected children in the US Perinatal AIDS Collaborative Transmission Study (1986-2004).
    Kapogiannis BG; Soe MM; Nesheim SR; Sullivan KM; Abrams E; Farley J; Palumbo P; Koenig LJ; Bulterys M
    Pediatrics; 2008 May; 121(5):e1229-39. PubMed ID: 18450865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.